Simvastatin and Ofirmev drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Simvastatin (simvastatin) and Ofirmev (acetaminophen). Common drug interactions include tachycardia among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Simvastatin and Ofirmev. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Simvastatin?

Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,970 Simvastatin users. Check the latest studies of Simvastatin.

What is Ofirmev?

Ofirmev has active ingredients of acetaminophen. eHealthMe is studying from 817 Ofirmev users. Check the latest studies of Ofirmev.



On Aug, 13, 2026

13 people who take Simvastatin and Ofirmev together, and have interactions are studied.

Simvastatin and Ofirmev drug interactions.

What are the common drug interactions of Simvastatin and Ofirmev, by gender? *:

female:

  1. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting
  4. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  5. Aspartate aminotransferase increased
  6. Asthenia (weakness)
  7. Blood alkaline phosphatase increased
  8. Blood bilirubin increased
  9. Chronic kidney disease
  10. Diarrhoea

male:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Abscess limb (limb infection)
  3. Tooth abscess (pus formation in tooth)
  4. Anal abscess
  5. Angioedema (rapid swelling of the dermis)
  6. Cardiac arrest
  7. Chronic kidney disease
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Genital abscess (build up of pus in genital)
  10. Liver disorder (liver diseases)

What are the common drug interactions of Simvastatin and Ofirmev, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Renal injury (kidney injury)

30-39:

n/a

40-49:

n/a

50-59:

  1. Abscess limb (limb infection)
  2. Cellulitis (infection under the skin)
  3. Groin abscess (pus in groin)
  4. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  5. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  6. Perineal abscess
  7. Scrotal abscess (pus in scrotum)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Septic shock (shock due to blood infection)
  10. Subcutaneous abscess

60+:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  3. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  4. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  5. Hypokalaemia (low potassium)
  6. Infection
  7. Nephropathy (damage to or disease of a kidney)
  8. Pneumonia
  9. Drug level increased
  10. Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

  1. High Blood Pressure: 3 people, 23.08%
  2. Diabetes: 3 people, 23.08%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
  4. Pain: 2 people, 15.38%
  5. Hypotension (abnormally low blood pressure): 2 people, 15.38%
  6. Weight Decreased: 2 people, 15.38%
  7. Type 2 Diabetes: 2 people, 15.38%
  8. Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 15.38%
  9. Chest Pain: 1 person, 7.69%
  10. Drowsiness: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Simvastatin and Ofirmev?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Simvastatin and Ofirmev:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ofirmev:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Simvastatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ofirmev and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on simvastatin and acetaminophen (the active ingredients of Simvastatin and Ofirmev, respectively), and Simvastatin and Ofirmev (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: